Trailing-twelve-month (TTM) revenue is $858.37 Million with a year-over-year growth of +24.01%. Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q2 FY2026Period ended 2025-09-30 | $190,880,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q3 FY2026Period ended 2025-12-31 | $198,589,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-03 |
| Q4 FY2026Period ended 2026-03-31 | $193,566,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-21 |
| Q1 FY2027Period ended 2026-06-30 | $275,331,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $858,366,000 |
Current P/S: $4,846,575,131 market capitalization ÷ $858,366,000 TTM revenue = 5.65x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T17:40:10.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q1 FY2027 (2026-06-30): $275.33M.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T17:42:20.764Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-10-05.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Incentive Fee Revenue, Customized Separate Accounts | $18M | $18M | $32M | $12M | $16M | $166M |
| Incentive Fee Revenue, Specialized Funds | $13M | $30M |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20212021-03-31 · USD | FY20222022-03-31 · USD | FY20232023-03-31 · USD | FY20242024-03-31 · USD | FY20252025-03-31 · USD | FY20262026-03-31 · USD |
|---|---|---|---|---|---|---|
| Non-US | N/A | N/A | N/A | N/A | N/A | $449M |
| Other Foreign Countries | $177M | $190M |
$858.37M
$858.37 Million
+24.01%
vs. $692.17M a year ago (TTM)
+19.59%
5 Year compound annual growth rate
1 Year
+24.01%
3 Year
+18.31%
5 Year
+19.59%
10 Year
+17.25%
15 Year
N/A
20 Year
N/A
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2026 | $758.99M | +$46.03M | +6.46% |
| 2025 | $712.96M | +$159.12M | +28.73% |
| 2024 | $553.84M | +$25.09M | +4.74% |
| 2023 | $528.75M | +$160.83M | +43.71% |
| 2022 | $367.92M | +$26.28M | +7.69% |
| 2021 |
TTM Growth
+24.01%
3-Year CAGR
+18.31%
5-Year CAGR
+19.59%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2026-03-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| $90M |
| $182M |
| $521M |
| Investment Performance | $31M | N/A | N/A | N/A | N/A | N/A |
|---|
| Management And Advisory Fee Revenue, Advisory | $26M | $25M | $25M | $24M | $23M | $20M |
|---|
| Management And Advisory Fee Revenue, Customized Separate Accounts | $94M | $103M | $118M | $129M | $134M | N/A |
|---|
| Management And Advisory Fee Revenue, Distribution Management | $7M | $10M | $3M | $5M | $3M | $2M |
|---|
| Management And Advisory Fee Revenue, Fund Reimbursement Revenue | $3M | $2M | $6M | $8M | $10M | $10M |
|---|
| Management And Advisory Fee Revenue, Reporting And Other | $11M | $23M | $25M | $25M | $29M | $36M |
|---|
| Management And Advisory Fee Revenue, Specialized Funds | $148M | $150M | $196M | $261M | $315M | N/A |
|---|
| $329M |
| $398M |
| N/A |
| UNITED STATES | $165M | $178M | $208M | $225M | $315M | $310M |
|---|
| $341.63M |
| +$67.59M |
| +24.66% |
| 2020 | $274.05M | +$21.87M | +8.67% |
| 2019 | $252.18M | +$8.15M | +3.34% |
| 2018 | $244.03M | +$64.21M | +35.71% |
| 2017 | $179.82M | ($977,000) | (0.54%) |
